People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
Dr Peter Mollee et al Princess Alexandra Hospital A Phase II Study of Risk-Adapted IV Melphalan in Patients with AL Amyloidosis Dr Peter Mollee. Investigators: Dr Peter Mollee, John ...
Clin Biochem Rev 2009;30(iii):93-103 Current Trends in the Diagnosis, Therapy and Monitoring of the Monoclonal Gammopathies. Peter Mollee
Dr Peter Mollee et al Princess Alexandra Hospital A Phase II Study of Risk-Adapted IV Melphalan in Patients with AL Amyloidosis Investigators: Dr Peter Mollee, John Bashford, Devinder ...
*For correspondence: Dr Peter Mollee e-mail: [email protected]. Aim: We studied the characteristics of small abnormal protein bands (APB) (including ...
Clin Biochem Rev Vol 30 August 2009 I 93 Review Article Current Trends in the Diagnosis, Therapy and Monitoring of the Monoclonal Gammopathies Peter Mollee Haematology Department ...
Sara L. Hall, Jill Tate,Devinder Gill,Peter Mollee 2009:30(iii):113 Abstract View Full Text (pdf) Serum and Urine Electrophoresis for Detection and ...
Dr Peter Mollee et al Princess Alexandra Hospital A Phase II Study of Risk-Adapted IV Melphalan in Patients with AL Amyloidosis Investigators: Dr Peter Mollee, John Bashford ...
Dr Peter Mollee et al Princess Alexandra Hospital A Phase II Study of Risk-Adapted IV Melphalan in Patients with AL Amyloidosis Dr Peter Mollee. Investigators: Dr Peter Mollee ...
[PDF]
[PDF]
Linkedin